World Scientific
Skip main navigation

Cookies Notification

We use cookies on this site to enhance your user experience. By continuing to browse the site, you consent to the use of our cookies. Learn More
×

System Upgrade on Tue, May 28th, 2024 at 2am (EDT)

Existing users will be able to log into the site and access content. However, E-commerce and registration of new users may not be available for up to 12 hours.
For online purchase, please visit us again. Contact us at customercare@wspc.com for any enquiries.
https://doi.org/10.1142/9781786344946_0002Cited by:0 (Source: Crossref)
Abstract:

The following sections are included:

  • Peripheral arterial disease (PAD) is an under-diagnosed, under-treated condition and its prevalence is increasing.

  • Patients with PAD have a cardiovascular risk profile equivalent to or worse than those with coronary or cerebrovascular disease.

  • PAD patients with concomitant symptomatic cardiac or cerebrovascular disease, diabetes or a low ankle pressure index are at even higher risk of sustaining a vascular event.

  • Patients with PAD should receive the same risk factor management as patients with other cardiovascular diseases.

  • Patient awareness of the need for cardiovascular secondary prevention therapy in PAD is low.

  • All PAD patients should be prescribed antiplatelet (clopidogrel preferably, if not on an anticoagulant) and statin, if tolerated.